News | March 24, 2025
AstraZeneca to invest $2.5 billion in new global strategic R&D centre in China
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company’s commitment to advancing respiratory care in India
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products
Nipaguard SCE Vita delivers comprehensive antimicrobial protection for personal care formulations
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
Subscribe To Our Newsletter & Stay Updated
